Who owns LEAP THERAPEUTICS INC?
- Ticker: CYPH
- CUSIP Number: 52187k200
Tip: Access positions for across all investors
Analyze quarterly positions in Leap Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Leap Therapeutics stock
Who bought or sold LEAP THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 2.3M | $1.9M | 0% | Mar 2026 |
|
| Vanguard Group | 2.1M | $2.5M | 83% | Dec 2025 |
|
| Vanguard Capital Management | 1.8M | $1.4M | 100% | Mar 2026 |
|
| Susquehanna International | 1.1M | $1.3M | 1053% | Dec 2025 |
|
| Geode Capital Management | 571k | $454k | 8% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 297k | $236k | 100% | Mar 2026 |
|
| Citadel Advisors | 252k | $200k | 1% | Mar 2026 |
|
| UBS Group | 171k | $136k | 449% | Mar 2026 |
|
| LPL Financial | 163k | $129k | 396% | Mar 2026 |
|
| State Street Corporation | 140k | $163k | 12% | Dec 2025 |
|
| Jane Street | 118k | $94k | 692% | Mar 2026 |
|
| Group One Trading | 107k | $85k | -34% | Mar 2026 |
|
| Texas Capital Bank Wealth Management Services | 104k | $83k | 0% | Mar 2026 |
|
| Key Client Fiduciary Advisors | 91k | $73k | 8% | Mar 2026 |
|
| Northern Trust | 88k | $102k | 42% | Dec 2025 |
|
| Simplex Trading | 68k | $79k | 1243% | Dec 2025 |
|
| Two Sigma Investments | 67k | $53k | -8% | Mar 2026 |
|
| Qube Research & Technologies | 63k | $73k | 100% | Dec 2025 |
|
| HighTower Advisors | 61k | $48k | 20% | Mar 2026 |
|
| Sequoia Financial Advisors | 48k | $38k | 0% | Mar 2026 |
|
| Hrt Financial | 38k | $29k | 100% | Mar 2026 |
|
| Morgan Stanley | 38k | $38k | 7617% | Mar 2026 |
|
| Gerber Kawasaki Wealth & Investment Management | 22k | $18k | 100% | Mar 2026 |
|
| Simplify Asset Management | 21k | $17k | -99% | Mar 2026 |
|
| Tower Research Capital | 13k | $15k | 100% | Dec 2025 |
|
| Keystone Financial Group | 12k | $9.3k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 12k | $9.2k | 100% | Mar 2026 |
|
| Cygnus Capital Advisors | 12k | $135k | 100% | Mar 2026 |
|
| Quadrant Private Wealth Management | 11k | $8.9k | 100% | Mar 2026 |
|
| IHT Wealth Management | 11k | $13k | 100% | Dec 2025 |
|
| William Blair $ Company | 10k | $7.9k | 0% | Mar 2026 |
|
| CNB Bank | 5.0k | $4.0k | 0% | Mar 2026 |
|
| Farther Finance Advisors | 2.1k | $1.6k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 1.9k | $2.1k | -2% | Dec 2025 |
|
| Huntington National Bank | 1.0k | $1.2k | 0% | Dec 2025 |
|
| Citigroup | 808.00 | $642.036800 | 100% | Mar 2026 |
|
| Western Wealth Management | 800.00 | $636.000000 | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 135.00 | $157.005000 | 0% | Dec 2025 |
|
| Tompkins Financial Corp | 120.00 | $95.004000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 100.00 | $0 | -23% | Mar 2026 |
|
| Hantz Financial Services | 8.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Leap Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Caitong International Asset Management | Dec 2025 | 38k | $44k |
| Toroso Investments | Dec 2025 | 35k | $41k |
| Millennium Management | Dec 2025 | 32k | $37k |
| XTX Topco | Sep 2025 | 31k | $14k |
| Baird Financial | Sep 2025 | 20k | $9.1k |
| Cetera Investment Advisers | Dec 2025 | 10k | $12k |
| Optima Capital | Dec 2025 | 798.00 | $925.999200 |
| Jpmorgan Chase & Co | Sep 2025 | 227.00 | $102.989900 |
| Fortitude Family Office | Dec 2025 | 182.00 | $210.992600 |